$28.56 0%
Price vs. AI Score (Last 150 days)
Data gathered: November 30

Data Bits

Data Bits Value / Change Benchmark
Job Posts 81 -1.2%
Sentiment 90 -5.3%
Webpage traffic 24,000 -12.5%
Employee Rating 78 0%
Google Adspend $ N/A N/A
Google Trends 13 -18.8%
Linkedin Employees 427 N/A
Patents 39 0%
4chan Mentions 0%
Stocktwits Mentions 2 -33.3%
Stocktwits Subscribers 4,656 -0%
News Mentions 0%
Reddit Mentions 0%
ESG 31 0%
Business outlook 79 0%

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news


About BridgeBio Pharma

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development.


BridgeBio Pharma
Price $28.56
Target Price Sign up
Market Cap $5.02B
Dividend Yield 0
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '234.1M600,000-17M-177M-156M
Q2 '231.6M600,000-18M-158M-137M
Q1 '231.8M650,000-49M-140M-119M
Q4 '22138M44M-59M-138M-225M
Q3 '22340,000740,000-55M-137M-117M

Insider Transactions

Kumar Neil filed to sell 4,813,197 shares at $29.6.
November 20 '23
STEPHENSON BRIAN C filed to sell 36,710 shares at $29.1.
November 20 '23
Valantine Hannah filed to sell 1,764 shares at $30.
November 17 '23
Scott Randal W. filed to sell 13,500 shares at $30.
September 7 '23
Kumar Neil filed to sell 4,813,197 shares at $28.6.
August 18 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.